The global Bone and Joint Health Supplement Market size was valued at USD 9.65 billion in 2024 and is predicted to reach USD 14.98 billion by 2030 with a CAGR of 7.6% from 2025-2030.
The market for bone and joint health supplements rises due to the booming geriatric population along with growing musculoskeletal disorders and rising overall awareness for general health and fitness globally. But the strict government policies and regulations restrain the growth in the market. On the contrary, introduction of natural and organic health supplements creates future opportunity for the market growth.
Moreover, the major players operating in the market are Amway and Abbott among others that adopts various business strategies including product launches and collaboration to exchange their market expansion and broaden their product offering. With the introduction of natural and organic supplements, the market is set for further revolution as organic supplements are more effective and tends to have lower side effect for the patients.
The rising aging population coupled with the health conditions such as arthritis and osteoporosis call for bone and joint health supplements. These diminishes such conditions and enhance the performance of the joints and aid in the general well-being of bones and muscles. By Union for International Cancer Control, in 2023, the older population worldwide summed 760 million, with estimated figures suggesting to grow up to 1.6 billion by the year 2050. An expanding aging population promotes demand for such health supplements and fosters market growth.
Widespread occurrence of calcium deficiency caused mainly due to poor dietary patterns increased the bone and joint health supplement market demand. This deficiency results in joint pains and a multitude of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and osteoporosis that makes bones weak. According to the International Osteoporosis Foundation osteoporosis affects one in three women and one in five men globally. The increase in cases amounts in demand for vitamin and calcium supplements that fuels the growth of the market.
The increase in health and fitness awareness further fuels the bone and joint health supplements market trends as more people engage in various sports activities according to their choices and due to this the demand for health supplements rises to support endurance and recover muscles of the athletes. These supplements improve overall physical performance by enabling consumers to maintain optimal health and elevate their athletic capabilities.
There exists presence of regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Food Safety Authority (EFSA) that impose stringent pre-market approval process coupled with product safety guidelines on the product. Such strict compliance delays the market entry of new product slowing the innovation process.
Introduction of organic and natural health supplements for conscious health consumers is anticipated to develop future opportunity in the market. Organic and natural ingredients in the bone and joint health supplements is anticipated to improve quality, ensuring a higher level of purity, safety, and efficiency.
The bone and joint health supplement market report is segmented on the basis of type, form, distribution channel, end-user and region. On the basis of type, the market is classified into vitamin D, vitamin K, calcium, collagen, omega 3-fatty acid, and glucosamine-chondroitin, minerals and others. On the basis of form, the market is classified into, tablets, capsules, liquid, powder, softgels, and others. On the basis of distribution channel, the market is segmented into supermarkets, pharmacies, health and wellness stores, and others. On the basis of end-user, the market is classified into children, adults, pregnant woman, elderly people, and others. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.
North America dominates the bone and joint health supplement market share and is expected to hold this position in the forecasted year due to the higher prevalence rate of osteoporosis leading to a greater requirement for supplements promoting bone health for the management of the condition.
According to Cleveland Clinic reports by 2023, more than 50 million Americans are experiencing osteoporosis. Osteoporosis on the rise within the region puts a high demand for a nutritional health supplement enhancing bone density with an increase in the strength of bones and with minimal risks to fracture.
Moreover, the higher engagement in sport activity leads to a higher demand for health wellness supplement as athletes need products that help them maintain joint health, recovery, and performance. According to the report by the Canadian Government released in 2023, over 55% of individuals 15 years and above reported involvement in sporting activities such as soccer, ice hockey, swimming and running. The increased population participating in sport activities boosts the demand for dietary health in order to harden bones, lubricate joints for flexibility and decrease inflammation in order to prevent injuries, thereby promoting growth in the market.
On the contrary, the Asia-Pacific region reveals a steady rise in the industry of bone and joint health supplement due to boosting aging population in this region. In Japan more than 1 in 10 persons are aged 80 or over as per World Economic Forum 2023. With such increase in lifespan, the threat of age-related musculoskeletal problems, such as osteoarthritis, and osteoporosis naturally rises, thus upsurging the demand for supplements to back these diseases.
Moreover, the presence of key market players such as Wada Calcium Pharm Co. Ltd. and By-Health Co. in this region is further boosting the market. This business players are adopting various business strategies including product launches to hold a dominant share in the market. For instance, in June 2024, Wada Calcium Pharm Co. Ltd. launched Foods with Function Claims (FCC) containing postbiotics and calcium maltobionate. The launch of this product aims to support bone and immune health in older adult.
Various market players operating in the bone and joint health supplement industry are Herbalife International of America, Inc., GNC Holdings, Inc., Nature’s Bounty Co., Bayer AG, By-Health Co., Ltd., Amway, BASF SE, Reckitt Benckiser Group plc, Vita Life Sciences Ltd., Pfizer Inc., Purovitalis, Oriflame, Protect and Gamble, Archer Daniels Minland, Arazo Nutrition, Abbott Laboratories, Wada Calcium Pharm Co., Ltd., Swanson, Nutramax Laboratories, Inc., Jarrow Formulas, Inc. and others. These market players are adopting various strategies such as product launches to remain dominant in the market.
For instance, in June 2024, Purovitalis launched Calcium-AKG (Calcium Alpha-Ketoglutarate) tablet. This nutritional supplement is employed for increasing the physical strength of human beings, improving bone growth, and aiding longevity.
On the contrary, in June of 2024, Wada Calcium Pharm Co., Ltd. launched Foods with Function Claims (FFC) specifically intended to cater to bone and immune health among adults. Such product development indicates that the company continued to conduct research and development for creating improved versions.
Oriflame recently launched its health supplements, Wellosophy, in July 2023. The supplement features iron complex, calcium, vitamin D, and magnesium, and caters as daily supplements for busy and support a healthy active lifestyle.
The report provides quantitative analysis and estimations of the bone health supplement market from 2025 to 2030, which assists in identifying the prevailing market opportunities.
The study comprises a deep-dive analysis of joint health supplement market including the current and future trends to depict prevalent investment pockets in the market.
Information related to key drivers, restraints, and opportunities and their impact on the bone and joint health supplement industry is provided in the report.
Competitive analysis of the players, along with their market share is provided in the report.
SWOT analysis and Porters Five Forces model is elaborated in the study.
Value chain analysis in the market study provides a clear picture of roles of stakeholders.
Vitamin D
Vitamin K
Calcium
Collagen
Omega 3-Fatty Acid
Glucosamine-Chondroitin
Minerals
Others
Tablets
Capsules
Liquid
Powder
Softgels
Others
Supermarkets
Pharmacies
Health and Wellness Stores
Others
Children
Adults
Pregnant Woman
Elderly People
Others
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Italy
Spain
Denmark
Netherlands
Finland
Sweden
Norway
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Singapore
Taiwan
Thailand
Rest of Asia-Pacific
RoW
Latin America
Middle East
Africa
Herbalife International of America, Inc.
GNC Holdings, Inc.
Nature’s Bounty Co.
Bayer AG
BY-HEALTH Co., Ltd.
Amway
BASF SE
Reckitt Benckiser Group plc
Vita Life Sciences Ltd.
Pfizer Inc.
Purovitalis
Oriflame
Protect and Gamble
Archer Daniels Minland
Arazo Nutrition
Abbott Laboratories
Wada Calcium Pharm Co., Ltd.
Swanson
Nutramax Laboratories, Inc.
Jarrow Formulas, Inc.
Parameters |
Details |
Market Size in 2024 |
USD 9.65 billion |
Revenue Forecast in 2030 |
USD 14.98 billion |
Growth Rate |
CAGR of 7.6% from 2025 to 2030 |
Analysis Period |
2024–2030 |
Base Year Considered |
2024 |
Forecast Period |
2025–2030 |
Market Size Estimation |
Billion (USD) |
Growth Factors |
|
Countries Covered |
28 |
Companies Profiled |
20 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent to up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |